Purchase Order W81K0021P0271
Award Date 10/1/21
Potential Completion Date 9/30/24
Potential Value $371K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
ARSENAL, PA 15201, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order contract was awarded by the Department of the Army Medical Command to Revvity Omics Inc., doing business as Perkinelmer Genetics, for comprehensive newborn screening services. The contract has a potential value of $375,186.00 and a completion date of September 30, 2016. Perkinelmer Genetics, a for-profit subsidiary of Revvity Inc., specializes in medical imaging and genetic testing services. This contract supports the military healthcare system by providing...
- This is a firm fixed price contract awarded by the Medical Command (MEDCOM) of the U.S. Army to Revvity Omics Inc., doing business as Perkinelmer Genetics, for newborn screening services at the William Beaumont Army Medical Center in Fort Bliss, Texas. The contract has a ceiling value of $99,600.00 and a performance period through October 31, 2017. Perkinelmer Genetics is a subsidiary of the parent company Revvity Inc., which specializes in medical imaging and genetic testing products and...
- This is a delivery order contract awarded by the Medical Command, a defense agency, to Revvity Omics Inc., doing business as Perkinelmer Genetics, for a total ceiling value of $82,500.00. The contract is for newborn screening testing services to be provided in Germany. The award is not associated with a larger contract vehicle, and there is no set-aside designation indicated. Perkinelmer Genetics is a subsidiary of the parent company Revvity Inc., which specializes in medical imaging and genetic...
- This is a firm fixed price contract awarded by the U.S. Department of Defense's Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics, for $91,840.00. The contract is for newborn screening services, which involves testing infants for conditions such as galactosemia, hypothyroidism, sickle cell disease, and cystic fibrosis. Perkinelmer Genetics is the prime contractor and does not appear to have any major subcontractors. This contract is not associated with a...
- This contract was awarded by the U.S. Department of the Army Medical Command to Perkinelmer Genetics, Inc., a for-profit medical services provider, to conduct newborn screening testing. The contract has a firm fixed price of $148,000.00 and a completion date of September 30, 2020. Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc., specializes in newborn and genetic screening services to support military hospitals and treatment facilities in the U.S. and overseas. This...
- This federal contract award is for newborn screening testing services provided by Revvity Omics Inc., doing business as Perkinelmer Genetics, to the Defense Health Agency (DHA) for the Brian D. Allgood Army Community Hospital (BDAACH) in South Korea. The contract is a firm fixed price delivery order under a larger indefinite delivery, indefinite quantity (IDIQ) contract awarded to Perkinelmer Genetics in 2019 by the DHA to provide newborn screening for Army medical facilities in Korea. The...
- Revvity Omics Inc., doing business as PerkinElmer Genetics, was awarded a $165,711.65 firm fixed-price purchase order by the Defense Health Agency on October 1, 2021, for newborn screening services at Fort Irwin, California. This contract represents an option year award under a broader newborn screening agreement and will remain in effect through September 30, 2026. As the prime contractor, Revvity Omics Inc. delivers comprehensive laboratory diagnostic capabilities focused on early detection of...
- This is a firm fixed-price blanket purchase agreement (BPA) call award issued by the U.S. Army Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics. The $150,000.00 contract is for newborn screening tests and does not have a set-aside designation. Perkinelmer Genetics is a for-profit subsidiary of Revvity Inc. that specializes in medical imaging and genetic testing services, particularly newborn screening programs that test infants for conditions like...
- The Department of the Army Medical Command awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening tests. The contract has a potential value of $143,440.00 and a performance period ending on September 30, 2018. Perkinelmer Genetics, a subsidiary of Revvity Inc., specializes in newborn and genetic screening services, and has provided similar testing support to military hospitals and treatment...
- This is a firm fixed price purchase order awarded by the Medical Command (MEDCOM) component of the U.S. Department of Defense for $75,810.00 to provide newborn screening testing services. The prime contractor is Revvity Omics Inc., doing business as Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc. The contract is for the delivery of specimen collection cards and performance of clinical laboratory analysis on newborn blood samples to screen for certain congenital metabolic...